Why Eli Lilly Stock Flopped on Friday

Eli Lilly (LLY -2.31%) stock was on quite a roll this young year, but a new development shifted that momentum on Friday. The shares fell as much as 3.2% in price on Friday afternoon, following the news that a top regulator is delaying a decision on one of the company's most important drug candidates.FDA decision on Alzheimer's drug delayedThat regulator is none other than the U.S. government's powerful Food and Drug Administration (FDA). On Friday, Eli Lilly said that the FDA has unexpectedly pushed back it ...